佛慈制药：10月28日召开董事会会议

Group 1 - The core viewpoint of the article highlights that 佛慈制药 (Foci Pharmaceutical) held its 10th meeting of the 8th Board of Directors on October 28, 2025, to review the Q3 2025 report and other documents [1] - For the first half of 2025, 佛慈制药's revenue composition was 99.89% from the pharmaceutical industry and 0.11% from the food industry [1] - As of the report, 佛慈制药's market capitalization stands at 4.6 billion yuan [1] Group 2 - The article also mentions that the A-share market has surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology leading the market's transformation [1]